Novel Cell Therapy
Novel Cell Therapy, Total:64 items.
The international standard classification for "Novel Cell Therapy" includes: Biology. Botany. Zoology , Medical materials , Medical Sciences and health care facilities in general .
The Chinese standard classification for "Novel Cell Therapy" includes: Biological agent and blood products , Extracorporeal circulation, artificial organ and prosthesis device , Medical apparatus and devices in general , Marking, packaing, transport and storage .
Group Standards of the People's Republic of China
- T/SHSYCXH 7-2022 Test method of human monocyte populations from peripheral blood-Flow cytometry
- T/SBX 055-2022 Test methods for tumorigenicity of stem cell therapy products
- T/SDHCST 001-2023 General Principles on the Non-Clinical Studies of the Cell Therapy Medical Products
- T/SDHCST 004-2023 Animal Species and Model Selection for Non-clinical Studies of the Cell Therapy Medical Products
- T/CSBT 009-2021 Technical guideline for genotyping of erythrocyte blood group
- T/CEAC 039-2024 Stem cell identification methods
- T/CACM 1369-2021 Guidelines for clinical diagnosis and treatment of high altitude polycythemia in Chinese medicine
- T/CITS 379-2025 Cellular immunophenotyping method based on flow cytometry
- T/GXDSL 005-2025 Quality Control Standards for Cold Chain Transportation of Cell Therapy Products
- T/CEAC 069-2024 Cell therapy Leukopak raw material collection and immune cell separation technical requirements
- T/CEAC 105-2025 TIL Cell Therapy Clinical Application Guidelines
- T/SHSYCXH 8-2022 Test method of human Natural Killer cells and Natural Killer T cells from peripheral blood-Flow cytometry
Professional Standard - Agriculture
- 142药典 三部-2015 Monograph II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
- 149药典 三部-2020 Monograph II Therapeutic Human Granulocyte Macrophage Stimulating Factor for Injection
- 150药典 三部-2020 Monograph Ⅱ Therapeutic topical human granulocyte macrophage stimulating factor gel
- 118药典 三部-2010 Chapter II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
- 农业部1719号公告-1-2012 Live swine fever vaccine (passage cell source) (new veterinary drug registration) (three types)
- 农业部公告第1793号 New veterinary drug: Recombinant avian influenza virus (H5N1 subtype) inactivated vaccine (cell source, Re-5 strain)
Professional Standard - Education
- JY 295-1987 Organelle Structure Model Specifications
- JY/T 0190-2011 plant cell model
- JY 190-1985 Plant Cell Model Technical Conditions
Professional Standard - Hygiene
- WS/T 245-2005 Reference method for the enumeration of erythrocytes and leucocytes
General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China
- GB/T 39730-2020 General requirements for cell counting—Flow cytometry
- GB/T 39729-2020 General requirements for measurement of cell purity—Flow cytometry
未注明发布机构
- NCCLS H7-A3-2000 Procedure for determination of hematocrit by microhematocrit method
Professional Standard - Medicine
- YY/T 1465.4-2017 Immunogenic evaluation method of medical devices-Part4:Phagocytosis of mouse peritoneal macrophages on chicken erythrocytes- Ex-vivo method
- YY/T 1500-2016 Pyrogen test for medical devices―Monocyte-activation test―Human whole blood ELISA method
- YY/T 1465.6-2019 Immunogenic evaluation method of medical devices―Part 6:Determination of animal spleen lymphocyte subsets by flow cytometry
- YY/T 0606.13-2008 Tissue Engineered Medical Product - Part 13: Standard Test Method for Automated Enumeration of Cell Suspensions
Shanghai Provincial Standard of the People's Republic of China
- DB31/T 687-2013 Basic requirements for clinical cell therapy platform settings
Hebei Provincial Standard of the People's Republic of China
- DB13/T 5332-2021 Technical specification for clinical operation of cellular immunotherapy
Professional Standard - Pharmaceutical Packaging
- YBB 0001-2003 Xibao Duxing Jianchafa Tests for cytotoxicity
Kingdom of Bahrain Testing and Metrology Directorate
- BH GSO ASTM F3206:2023 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
GCC Standardization Organization
- GSO ASTM F3206:2022 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
American Society for Testing and Materials (ASTM)
- ASTM F3206-17 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
- ASTM F3368-19 Standard Guide for Cell Potency Assays for Cell Therapy and Tissue Engineered Products
- ASTM D3576-20 Standard Test Method for Cell Size of Rigid Cellular Plastics
- ASTM F895-25 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
- ASTM D3576-25 Standard Test Method for Cell Size of Rigid Cellular Plastics
- ASTM E2526-22 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
- ASTM F895-84(2001)e1 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
- ASTM F895-84(2006) Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
- ASTM D6226-21 Standard Test Method for Open Cell Content of Rigid Cellular Plastics
- ASTM E2526-08 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
British Standards Institution (BSI)
- BS PAS 84:2012 Cell therapy and regenerative medicine. Glossary
- BS PAS 83:2006 Guidance on codes of practice, standardised methods and regulations for cell-based therapeutics
- BS EN 30993-5:1994 Biological evaluation of medical devices-Tests for cytotoxicity, in vitro methods
- BS ISO 20391-1:2018 Biotechnology. Cell counting. General guidance on cell counting methods
- BS 5736-10:1988 Evaluation of medical devices for biological hazards-Method of test for toxicity to cells in culture of extracts from medical devices
American Water Works Association (AWWA)
- AWWA WQTC55045 New Rapid Methods to Track Diluted Enterobacteriaceae Cells in Drinking Waters
- AWWA WQTC56962 Concentration and Detection of Microsporidia Using a Newly-Modified Continuous Flow Centrifuge and Flow Cytometry
Korean Agency for Technology and Standards (KATS)
- KS C 7006-1971(2000) TYPE DESIGNATION SYSTEM FOR PHOTOCONDUCTIVE CELLS
- KS C 7006-1985 TYPE DESIGNATION SYSTEM FOR PHOTOCONDUCTIVE CELLS
- KS P 1600-2018(2023) General guideline of safety test for the cell based therapeutic substances
- KS P 1600-2023 General guideline of safety test for the cell based therapeutic substances
- KS J ISO 21973-2023 Biotechnology — General requirements for transportation of cells for therapeutic use
American National Standards Institute (ANSI)
- ANSI/NCCLS H7-A 2-1996 Procedure for Determining Packed Cell Volume by the Microhematocrit Method
Bureau of Indian Standards
- IS 17711-2021 Biotechnology General requirements for transportation of cells for therapeutic use
International Organization for Standardization (ISO)
- ISO 21973:2020 Biotechnology — General requirements for transportation of cells for therapeutic use
Canadian Standards Association (CSA)
- CAN/CSA Z900.2.5-2012 Lymphohematopoietic Cells for Transplantation, Includes Update No. 1 (2013), Update No. 2 (2016)
IT-UNI
- UNI ISO 21973:2021 Biotechnology - General requirements for transportation of cells for therapeutic use
IPC - Association Connecting Electronics Industries
- IPC TM-650 2.3.21-1976 Plating Quality Hull Cell Method
Ente Nazionale Italiano di Unificazione
- UNI EN ISO 13366-1:1998 Milk - Enumeration of somatic cells - Microscopic method
Gosstandart of Russia
- GOST R ISO 10993.5-1999 Medical devices. Biological evaluation of medical devices. Part 5. Tests for cytotoxicity: in vitro methods
cell therapy,cell therapy,cell-directed therapy,red blood cell therapy,cell therapy,pericyte therapy,cell therapy,Novel Cell Therapy,target cell therapy,target cell therapy,Cell Regenerative Therapy,new therapy,new cell,Various Cell Therapies,mononuclear cell therapy,Beijing Cell Therapy,medical cell therapy,Therapy Cell Therapy,Cell Therapy+,multicellular therapy